Saturday, October 29, 2016: 10:30 AM-12:00 PM
Room: La Nouvelle Orleans Ballroom
Learning Objectives:
At the conclusion of this session, participants will be able to:
- summarize current recommendations for prescribing and monitoring PrEP
- identify factors contributing to an HIV and HCV epidemic within a community of injection drug users and explain key prevention interventions to prevent HIV and HCV transmission within a community
- describe STDs among PrEP users and implement strategies to prevent STD acquisition and transition with patients taking PrEP
Target Audience: Fellows, HIV clinicians, HIV specialists, Infectious diseases physicians, Members-in-training, Public health practitioners
Tracks: HIV-STD-TB, Adult ID
Moderators:
Jeanne Marrazzo, MD, MPH, FIDSA, FACP, University of Alabama, Birmingham
and
Emily Erbelding, MD, MPH, FIDSA, National Institutes of Health
Presentations:
CME Credits: Maximum of 1.5 hours of AMA PRA Category 1 Credit™
ACPE Credits: ACPE 1.5 knowledge-based contact hours .15 of pharmacy CE
ACPE Number: 0221-9999-16-291-L02-P
Disclosures:
J. Marrazzo,
None
See more of: Symposium